On June 16, Ali Health fell 3.12% in regular trading, trading at 3.41 HKD/share, with turnover of approximately 56.08 million HKD.

On the news front, persistent global liquidity tightening signals have weighed heavily on Hong Kong-listed technology and healthcare stocks. Analysts noted that the U.S. Federal Reserve's next policy adjustment could be a rate hike, with Danske Bank's senior analyst forecasting 25 basis-point hikes in December and March next year respectively. The broader sector displayed notable weakness, with PA Good Doctor falling 5.88%, JD Health declining 2.91%, and Meituan dropping 2.75%.

Market participants pointed to a combination of tightening external liquidity conditions and prior excessive gains in the sector as catalysts for selling pressure. The so-called seesaw effect between Japanese/Korean equities and Hong Kong stocks has re-emerged, historically signaling tightening global liquidity. Institutional views suggest that current hawkish rate expectations may be overdone, with potential downward revision offering future valuation recovery opportunities for leading internet platforms.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)